Lv1
38 积分 2022-04-04 加入
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results
4天前
已完结
CAR-T cell therapy targeting MUC17 in gastric tumors
5天前
已关闭
Innovative CAR-T approaches targeting Claudin 18.2 to counteract drug resistance in gastric cancer
5天前
已关闭
Anbenitamab in previously treated HER2-positive gastric cancer (KC-WISE): prespecified interim analysis of a randomized, phase III clinical trial
14天前
已完结
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
22天前
已完结
Efficacy and safety of S-1 plus oxaliplatin combined with apatinib and camrelizumab as neoadjuvant therapy for patients with locally advanced gastric or gastroesophageal junction adenocarcinoma: a protocol for a single-arm phase II trial
1个月前
已完结
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
2个月前
已完结
Apatinib plus hepatic arterial infusion of oxaliplatin and raltitrexed for hepatocellular carcinoma with extrahepatic metastasis: phase II trial
6个月前
已完结
Apatinib plus hepatic arterial infusion of oxaliplatin and raltitrexed for hepatocellular carcinoma with extrahepatic metastasis: phase II trial
6个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
7个月前
已完结
皖公网安备34019202002308
